Study of 100,000 Americans Identifies Thousands of New Genetic Variants Affecting Drug Response
Source Summary
Researchers analyzing data from nearly 100,000 diverse Americans discovered thousands of previously unknown genetic variants that influence how individuals respond to prescription medications. The findings expand understanding of pharmacogenomics—the study of how genetic differences affect drug efficacy and safety. This large-scale, diverse population study provides new insights into personalized medicine approaches.
Why it matters
Identifying genetic variants that affect drug response enables more precise medication selection and dosing, potentially improving treatment outcomes and reducing adverse drug reactions across diverse populations.
